Arch Therapeutics's market cap is currently $1.07M. The company's EPS TTM is $-2.856; its P/E ratio is ―; Arch Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 75.72K	$ 15.65K	$ 11.56K	$ 0.00	$ 0.00
Gross Profit	$ -2.44K	$ -35.84K	$ -14.72K	$ -6.93K	$ -8.24K
Operating Income	$ -5.04M	$ -5.71M	$ -6.38M	$ -5.37M	$ -6.37M
EBITDA	$ -3.88M	$ -4.71M	$ -6.09M	$ -5.35M	$ -6.36M
Net Income	$ -6.98M	$ -4.28M	$ -6.57M	$ -4.01M	$ -2.72M
Balance Sheet
Cash & Short-Term Investments	$ 222.72K	$ 746.94K	$ 2.27M	$ 959.31K	$ 2.18M
Total Assets	$ 1.96M	$ 2.60M	$ 3.68M	$ 2.15M	$ 2.90M
Total Debt	$ 5.63M	$ 3.36M	$ 1.60M	$ 726.30K	$ 0.00
Net Debt	$ 5.41M	$ 2.62M	$ -666.64K	$ -233.01K	$ -2.18M
Total Liabilities	$ 9.47M	$ 6.80M	$ 4.70M	$ 3.65M	$ 3.71M
Stockholders' Equity	$ -7.51M	$ -4.19M	$ -1.03M	$ -1.50M	$ -807.30K
Cash Flow
Free Cash Flow	$ -3.38M	$ -4.46M	$ -5.96M	$ -5.05M	$ -5.27M
Operating Cash Flow	$ -3.37M	$ -4.46M	$ -5.96M	$ -5.04M	$ -5.27M
Investing Cash Flow	$ -4.52K	$ 0.00	$ -3.27K	$ -2.46K	$ 0.00
Financing Cash Flow	$ 2.85M	$ 2.94M	$ 7.27M	$ 3.83M	$ 2.78M

Currency in USD

Arch Therapeutics Earnings and Revenue History

Income Statement >

Arch Therapeutics Debt to Assets

Balance Sheet >

Arch Therapeutics Cash Flow

Cash Flow >

Arch Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing